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Abstract 
This report presents the case of a 70-year-old woman with a previous history of a left 
nephrectomy for renal cell carcinoma (RCC), who developed general malaise and fatigue. 
Abdominal computed tomography demonstrated an enhancing 6 × 7 cm necrotic lesion 
in the lower pole of the spleen suggestive of a metastasis. Given the highly suspicious 
nature of the lesion we proceeded to splenectomy. The tumour did not breach the 
splenic capsule, and there was no local diaphragmatic involvement. The mass was 
concluded to be a true metastasis of the original RCC rather than local recurrence of the 
disease. The causes of isolated solid splenic lesions are wide and varied, however a past 
or present history of malignancy should lead to a high index of suspicion for a splenic 
metastasis. We report an extremely unusual case of spread from a RCC. 
Introduction 
Metastasis to the spleen is infrequent but varies greatly from series to series (1.6 to 
30%), depending on the thoroughness of examination and selection of cases [1]. The most 
common primaries are lung cancer, cutaneous malignant melanoma, and breast cancer 
[2]. Splenic metastasis generally indicates late dissemination of disease, and it is unusual 
to find isolated splenic lesions from solid organ malignancies, with fewer than 25 cases 
reported worldwide [3]. Spread from renal cell carcinoma (RCC) is extremely unusual. 
We report the case of a woman who presented with a splenic lesion 11 months after 
radical nephrectomy.  
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Case Report 
A 70-year-old Caucasian female presented with a 4-week history of malaise and fatigue. She 
had undergone a left radical nephrectomy for RCC 11 months earlier. This renal tumour had 
been incidentally discovered on a follow-up abdominal CT scan she was having following a total 
abdominal hysterectomy and adjuvant radiotherapy for stage 1c endometrial carcinoma 4 years  
prior. 
Histological examination of the renal mass had shown a tumour of conventional clear cell 
type. There was some invasion of the tumour into the perinephric fat and a segmental branch of 
left renal vein (stage pT3b). Small deposits of tumours were noted on the surface of the fat resection 
margin. In light of this and the associated increased risk of recurrence, she received a follow-up 
un-enhanced CT 6 months post-operatively which showed no recurrence, and was due further 
urological follow-up prior to her new presentation to the general practitioner 11 months 
post-nephrectomy with lethargy. 
At this time she was found to be anaemic (haemoglobin 10.4 g/dl) and had a raised alkaline 
phosphatase level of 188 IU/l (the remainder of liver function tests were normal). A CT scan revealed 
an enhancing 6 × 7 cm necrotic lesion in the lower pole of the spleen, thought to be a metastasis from 
her previous RCC, with her previous endometrial carcinoma being a less likely primary. It was 
uncertain whether this was indeed a true metastasis or a local recurrence of her previous left renal 
tumour. There was no evidence of any other metastatic disease on cross-sectional imaging of the chest 
and abdomen. After discussion in a multidisciplinary setting, although an uncommon event, the splenic 
lesion was thought likely to be an isolated splenic metastasis from her previous RCC and resection was 
recommended. Laparoscopic biopsy was not thought to be helpful in this case. The patient was carefully 
counselled and her fitness for resectional surgery assessed. She elected to undergo surgery (open 
splenectomy), had an uncomplicated procedure/recovery and was discharged from hospital on the 
eighth post-operative day. 
The removed spleen weighed 450 g and measured 120 × 105 × 70 mm. Serial slicing revealed a 
circumscribed centrally necrotic cream-coloured tumour measuring 90 × 63 × 55 mm (fig. 1). In 
addition, two fragments of diaphragmatic tissue were sampled to assess for any evidence of tumour 
spread.  
Histological examination of the splenic lesion showed a well-circumscribed, partly encapsulated 
tumour of solid islands and sheets of cells with an abundant amount of predominantly clear but also 
eosinophilic cytoplasm (fig. 2). Widespread necrotic foci were noted. The tumour was found to bulge 
into the splenic capsule but no definite evidence of capsular breach was found. There was also no 
evidence of vascular invasion and the lesion was clear of the splenic hilum.  
No evidence of disease was found in histological samples taken from the diaphragm and therefore 
the mass was concluded to be a true metastasis of the original RCC rather than local recurrence of the 
disease. The patient has received on-going follow-up under the care of the urology team, with 
6-monthly CT scans which have thus far not shown any evidence of disease recurrence 24 months 
post-splenectomy. 
Discussion 
The causes of isolated solid splenic lesions are wide and varied, and as such can present 
a diagnostic challenge. A splenic mass without any history of malignancy suggests a 
primary lesion such as lymphoma, vascular tumours or infectious lesions. Any past or 
present history of malignancy however would lead to a high index of suspicion for a 
splenic metastasis [4]. In the presence of isolated splenic metastasis, it must always be 
considered that there is an undiagnosed primary lesion. Interestingly this has been 
described by McGregor et al. who reported a clinically unidentified RCC diagnosed by 
fine needle aspiration of the spleen [5]. Further differential diagnoses for isolated splenic 
mass include rarer lesions such as hamartoma and inflammatory pseudotumour, which  
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can both clinically and radiologically mimic a metastatic tumour [4]. One should also 
consider the possibility of secondary involvement of the spleen through direct invasion, 
for example from a RCC [6]. 
Splenic metastases were previously considered exceptionally rare, however more 
recent advances in radiological imaging and the increased follow-up of patients with 
cancer means that the rate of detection has increased [7]. Splenic metastases are often 
asymptomatic. An autopsy study found only 8% of 92 patients with secondary 
non-lymphoid splenic lesions at autopsy were symptomatic. These symptoms included 
an enlarging abdominal mass or abdominal pain [8]. 
The majority of splenic metastases are part of a multi-visceral metastatic disease, and 
the detection is often made soon after diagnosis of the primary tumour (mean duration 
after detection of primary tumour is 6.7 months), however this is often late in the course 
of disseminated disease [8]. There has however been a case of splenic metastasis 5 years 
after a radical prostatectomy for prostate carcinoma [9]. This case, along with recent 
advances in the knowledge of the metastatic process, makes it seem likely that late 
occurrence of solitary splenic metastases might develop from early blood-borne 
micrometastasis within the spleen after a period of clinical latency [4]. 
In an autopsy study of splenic metastasis, the rate of dissemination to the spleen was 
highest from lung cancer, cutaneous malignant melanoma, and breast cancer, accounting 
for 24.6, 15.8, and 12.3% of all spleen metastases, respectively [2]. RCC has been reported 
to have spread to nearly every organ; however the incidence of splenic metastasis is 
relatively low, with a 4.6% incidence in an autopsy study [10]. 
To our knowledge there have been only 8 cases of a splenic metastasis from a RCC that 
presented clinically and has been reported on, including our study [11–17]. The incidence 
of isolated splenic metastasis from any given primary is also particularly rare, with only 
5.3% being found to be isolated at autopsy [8]. 
The reason for the relative rarity of splenic metastases might be explained by two main 
causes: (1) mechanical factors impeding the splenic implantation of blood-borne cancer 
cells, such as the constant flow of blood through the spleen and the rhythmic contraction 
of the splenic capsule, the sharp angle of the splenic artery branching from the coeliac 
trunk thus preventing large clumps of tumour cells from passing through, and the lack of 
afferent lymphatic vessels limiting lymphogenic metastases, and (2) the inhibitory effect 
of the splenic microenvironment on the growth of metastatic cells [18]. 
Advances in imaging techniques have not only resulted in an increase in the detection 
of splenic lesions, but also in the cellular diagnosis using percutaneous biopsy (using 
ultrasound or CT guidance) [7, 19] or endoscopic fine needle aspiration [20]. 
Given that a splenic metastasis is often found in the context of disseminated 
malignancy, it tends to have no clinical importance. A splenectomy however can be 
indicated for palliative symptomatic relief, with reports of acceptable morbidity and 
improvements in quality of life [21].  
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Conclusion 
The incidence of a solitary splenic metastasis from a RCC is particularly rare. They are 
often asymptomatic and picked up either incidentally or on surveillance imaging for 
previous malignancy. A splenectomy is an effective and safe option for symptomatic relief 
and prevention of future complications. 
Disclosure Statement 
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Fig. 1. Macroscopic appearance of removed spleen containing tumour. 
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Fig. 2. Histology from splenic metastasis showing tumour cells with both clear and eosinophilic 
cytoplasm. The cells have moderately pleomorphic nuclei, some with very prominent nucleoli. Focally 
multilobulated nuclei are also seen. 
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